Event Details
- Event Type: Earnings Conference Call for analysts and investors
- Purpose: To discuss the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026 (Q2FY27 and H1FY27)
- Date: Friday, November 6, 2026
- Time: 11:00 AM to 12:00 PM IST
Management Participation
The conference call will feature representation from senior management including:
- Mr. Krishna Kanumuri, Managing Director & Chief Executive Officer
- Mr. Siva Chittor, Whole-Time Director and Chief Financial Officer
Additional Information
Company Background
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970) is described as one of India's fastest growing Contract Research, Development, and Manufacturing Organizations (CRDMO) that partners with innovator pharmaceutical and biotech companies. The company is headquartered in Hyderabad, India with a global presence, offering integrated solutions spanning medicinal chemistry, process development, clinical and commercial manufacturing, and advanced technology platforms.
Document Metadata
- Submitted by: Runa Karan, Company Secretary & Compliance Officer (Membership No. A13721)
- Regulatory Reference: Regulation 30 of SEBI Listing Regulations